Marshall Wace’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Marshall Wace’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,338	Closed	-$1.22M	–	3435
2025 Q4	$1.22M	Buy	+14,338	New	+$1.14M	﹤0.01%	1834
2024 Q4	–	Sell	-8,398	Closed	-$593K	–	2771
2024 Q3	$593K	Buy	8,398 +2,034	+32%	+$142K	﹤0.01%	1865
2024 Q2	$422K	Buy	+6,364	New	+$417K	﹤0.01%	2022
2023 Q2	–	Sell	-5,118	Closed	-$299K	–	2684
2023 Q1	$299K	Sell	5,118 -2,100	-29%	-$127K	﹤0.01%	2299
2022 Q4	$448K	Sell	7,218 -1,200	-14%	-$72.2K	﹤0.01%	2414
2022 Q3	$475K	Buy	8,418 +4,830	+135%	+$298K	﹤0.01%	2760
2022 Q2	$229K	Sell	3,588 -366	-9%	-$23.2K	﹤0.01%	3124
2022 Q1	$256K	Buy	3,954 +2,178	+123%	+$138K	﹤0.01%	3013
2021 Q4	$118K	Buy	+1,776	New	+$113K	﹤0.01%	3340

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Marshall Wace's IHE Position: Q1 2026 in Review

Marshall Wace sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2026, closing a stake of 14,338 shares — an estimated $1.22M sold.

Marshall Wace first reported a position in IHE in Q4 2021 and held it in 9 quarters. The position peaked at $1.22M in Q4 2025. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

Marshall Wace reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
Marshall Wace sold 14,338 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $1.22M.
Marshall Wace first reported a position in iShares US Pharmaceuticals ETF in Q4 2021 and held it in 9 quarters.
Marshall Wace's iShares US Pharmaceuticals ETF position peaked at $1.22M in Q4 2025.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.